Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 27, 2015 10:05 ET | Source: Forward Pharma A/S

Forward Pharma Receives Decision to Grant From EPO for DMF Patent in Europe

COPENHAGEN, Denmark, April 27, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (the "Company") announced today that the Company received a decision to grant from the European Patent Office...
April 14, 2015 11:22 ET | Source: Forward Pharma A/S

U.S. Patent Office Declares an Interference Between Forward Pharma and Biogen Regarding the Treatment of Multiple Sclerosis With 480 mg Daily Dose of DMF, the Active Ingredient in Tecfidera(R)

COPENHAGEN, Denmark, April 14, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (the "Company") announced today that an interference was declared by the Patent Trial and Appeal Board (PTAB)...
April 09, 2015 17:31 ET | Source: Forward Pharma A/S

Forward Pharma Pre-IPO Investors Voluntarily Agree to Extend Lock-Up

COPENHAGEN, Denmark, April 9, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (the "Company" or "Forward") announced today an agreement among all of its pre-IPO shareholders to voluntarily...
March 25, 2015 06:30 ET | Source: Forward Pharma A/S

Forward Pharma Reports Fourth Quarter and Year End 2014 Financial and Operational Results

COPENHAGEN, Denmark, March 25, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP), today reported financial results for the fourth quarter and year ended December 31, 2014. Net loss for the...
March 16, 2015 08:30 ET | Source: Forward Pharma A/S

Forward Pharma CFO to Present at the Future Leaders Conference on March 20th

COPENHAGEN, Denmark, March 16, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP), a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate for the treatment...
February 05, 2015 08:30 ET | Source: Forward Pharma A/S

Forward Pharma CFO to Present at Two Upcoming Conferences in February

COPENHAGEN, Denmark, Feb. 5, 2015 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP), a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate for the treatment...
November 24, 2014 08:30 ET | Source: Forward Pharma A/S

Forward Pharma Receives Issue Notification for Erosion Matrix Patent in the U.S.

COPENHAGEN, Denmark, Nov. 24, 2014 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) ("the Company") announced today that the Company received an issue notification from the United States Patent and...
November 18, 2014 08:30 ET | Source: Forward Pharma A/S

Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany

COPENHAGEN, Denmark, Nov. 18, 2014 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) announced today that it has filed a lawsuit against Biogen Idec GmbH, Biogen Idec International GmbH and Biogen...
November 14, 2014 16:10 ET | Source: Forward Pharma A/S

Forward Pharma A/S Announces Closing of Partial Exercise of Over-Allotment Option

COPENHAGEN, Denmark, Nov. 14, 2014 (GLOBE NEWSWIRE) -- Forward Pharma A/S (the "Company") (Nasdaq:FWP), a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate...
November 14, 2014 06:30 ET | Source: Forward Pharma A/S

Forward Pharma CFO to Present at Two Upcoming Conferences

COPENHAGEN, Denmark, Nov. 14, 2014 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP), a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate for the treatment...